Physician profile
Arthur Grant
NPI 1649382961
$6,037.30
in general payments reported to CMS, 2019-2025
14 companies · $1,530 in 2025
The $1,530 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,441 · 2020: $75.50 · 2021: $305 · 2022: $516 · 2023: $1,186 · 2024: $983 · 2025: $1,530.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,699.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,699.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sk Life Science, INC. | $2,286.90 | 2020-2025 | Xcopri |
| Ucb Sa | $1,389.80 | 2019 | |
| Neurelis, INC. | $733.41 | 2022-2025 | Valtoco |
| Ucb, INC. | $327.98 | 2020-2023 | Fintepla |
| Aucta Pharmaceuticals, INC. | $298.82 | 2024-2025 | Motpoly Xr |
| Jazz Pharmaceuticals INC. | $287.77 | 2025 | Epidiolex |
| Sunovion Pharmaceuticals INC. | $210.31 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $205.63 | 2023-2024 | Aptiom |
| Livanova USA, INC. | $170.38 | 2021-2024 | Vns Therapy Sentiva Model 1000 Generator |
| Ceribell, INC. | $60.71 | 2025 | Pocket Eeg Device |
| Eisai INC. | $24.92 | 2022 | |
| Medtronic USA, INC. | $24.79 | 2019 | |
| Supernus Pharmaceuticals, INC. | $15.88 | 2021 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Grant listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.